vimarsana.com

Page 252 - வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 patients at higher risk of death, health problems than those with flu | The Source

Shown is a rendering of SARS-CoV-2, which causes COVID-19. (Image: Getty Images) Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month. From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated widely, suggesting it is less deadly or flu’s equal. Evidence is accumulating, however, to show just how much deadlier COVID-19 is compared with the flu and the extent of complications related to the two illnesses. The new research a deep dive into federal data by researchers at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System reveals a clearer distinction between the two contagious viruses: Among hospitalized patients, COVID-19 was associated with an increased need for ventilators, more admissions into intensive care units (ICUs), longer hospital stays and nea

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month. From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated widely, suggesting it is less deadly or flu s equal. Evidence is accumulating, however, to show just how much deadlier COVID-19 is compared with the flu and the extent of complications related to the two illnesses. The new research a deep dive into federal data by researchers at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System reveals a clearer distinction between the two contagious viruses: Among hospitalized patients, COVID-19 was associated with an increased need for ventilators, more admissions into intensive care units (ICUs), longer hospital stays

Breaking down COVID vaccine trials with two St Louis researchers

The way out : Trials in St. Louis helped build a 95% effective vaccine Work persists at SLU, Washington University as first batches roll out Scott Marion, smarion@edwpub.net FacebookTwitterEmail Dr. Sharon Frey, clinical director of St. Louis University’s Center for Vaccine Development, serves as the principal investigator of the COVID-19 vaccine trials at SLU.St. Louis University photo ST. LOUIS With the first batches of the COVID-19 vaccine rolling out this week across the United States, several researchers from the St. Louis area are part of the effort to end the pandemic. Researchers at the St. Louis University Center for Vaccine Development and Washington University School of Medicine are participating in COVID-19 vaccine trials, with each school participating in different trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.